Bacteria-Resistant Implant Surface Using Multi-Phase Oxide Coatings
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional implant materials are susceptible to bacterial accumulation, leading to inflammatory reactions and complications, especially in immunosuppressive patients, and existing antibacterial solutions like silver or copper can be cytotoxic and hinder osseointegration.
Innovation Solution
Development of a bacteria-resistant and repellent surface using chemically stable oxides from subgroups IV and V of the Periodic Table, such as tantalum and niobium oxides, with a negatively charged, multi-phase structure that denatures pathogenic bacteria without affecting cell adhesion for tissue integration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If silver or copper doping is used to achieve antibacterial effect, then bacterial resistance is improved, but cytotoxicity increases and osseointegration is hindered
Solution Approach 1:
The patent changes the chemical composition parameters by using oxide materials (titanium oxide, zirconium oxide, hafnium oxide) instead of metallic silver or copper. The specific oxide composition ratios are optimized to achieve antibacterial effects while maintaining biocompatibility and avoiding cytotoxicity associated with metal doping.
Solution Approach 2:
The patent employs composite oxide surfaces combining multiple metal oxides (titanium oxide, zirconium oxide, hafnium oxide) in specific ratios. This composite structure synergistically enhances antibacterial properties while maintaining biocompatibility, avoiding the cytotoxic effects of single-metal doping approaches.
2Ease of manufacture
If conventional implant materials are used, then manufacturing simplicity is maintained, but bacterial accumulation occurs leading to inflammatory reactions
Solution Approach 1:
The patent modifies surface chemical parameters by applying oxide coatings with specific compositions and surface charges. These parameter changes enable bacterial resistance while maintaining compatibility with conventional implant manufacturing processes, avoiding complete redesign of the implant structure.
3Reliability
If titanium surfaces are used, then biocompatibility is achieved, but plaque formation occurs on the surface
Solution Approach 1:
The patent applies local quality modification by creating oxide surfaces with specific local chemical compositions and surface charge characteristics. The oxide layer provides localized antibacterial properties at the implant surface while maintaining overall biocompatibility, preventing plaque formation without compromising tissue integration.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The surface effectively prevents pathogenic bacteria adhesion, maintains biocompatibility, and promotes cell attachment and proliferation, reducing the risk of inflammatory reactions and implant failure.
Implementation Method 1
High electric field strengths at the 'inorganic surface - biological environment' interface are intended to cause the denaturation of adsorbed macromolecules
Implementation Method 2
The surfaces are structured negatively or completely negatively charged and therefore have a repulsive effect on the bacteria
Implementation Method 3
Among other things, electrostatic forces with hydrophobic interactions work here
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The invention relates to a bacteria-resistant and bacteria-repellent, biocompatible, chemically stable surface for implant surfaces, which is multiphase or forms a heterogeneous mixed phase and is at least bipolar, wherein at least one phase has a pzzp in physiological environment of 5 or more.